1. Homology Medicines Appoints Matthew R. Patterson to Board of Directors

    Homology Medicines Appoints Matthew R. Patterson to Board of Directors

    BEDFORD, Mass., Jan. 17, 2018 /PRNewswire/ -- Homology Medicines, a genetic medicines company, announced today the appointment of Matthew R. Patterson, Co-Founder, President and Chief Executive Officer of Audentes Therapeutics, to Homology's Board of Directors . Mr. Patterson is a biotech ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned